Welcome to the InfoSci Platform
Reference Hub4
Performance Improvement Tool Towards the Medicines Manufacturing Pharmaceutical Companies Under Sustainable Practices

Performance Improvement Tool Towards the Medicines Manufacturing Pharmaceutical Companies Under Sustainable Practices

Kaminee Sahu, Seema Kohli
Copyright: © 2019 |Volume: 9 |Issue: 2 |Pages: 14
ISSN: 1947-8585|EISSN: 1947-8593|EISBN13: 9781522565772|DOI: 10.4018/IJEEI.2019070103
Cite Article Cite Article

MLA

Sahu, Kaminee, and Seema Kohli. "Performance Improvement Tool Towards the Medicines Manufacturing Pharmaceutical Companies Under Sustainable Practices." IJEEI vol.9, no.2 2019: pp.35-48. http://doi.org/10.4018/IJEEI.2019070103

APA

Sahu, K. & Kohli, S. (2019). Performance Improvement Tool Towards the Medicines Manufacturing Pharmaceutical Companies Under Sustainable Practices. International Journal of E-Entrepreneurship and Innovation (IJEEI), 9(2), 35-48. http://doi.org/10.4018/IJEEI.2019070103

Chicago

Sahu, Kaminee, and Seema Kohli. "Performance Improvement Tool Towards the Medicines Manufacturing Pharmaceutical Companies Under Sustainable Practices," International Journal of E-Entrepreneurship and Innovation (IJEEI) 9, no.2: 35-48. http://doi.org/10.4018/IJEEI.2019070103

Export Reference

Mendeley
Favorite Full-Issue Download

Abstract

It is observed that the pollution of hospitals is escalated due to the propagation of diseases across the world. The medicine production companies are known as pharmaceutical companies; reserve the different kinds of drug stocks to be supplied to their partners. It is investigated that presently, the patient deaths are hiked due to the delay in drug delivery to hospitals by pharmaceutical companies. It became necessary for pharmaceutical companies to map own supply chain practices, so that the death cases of patients can be eliminated. Pharmaceutical companies are seeking the decision support model with computing technique, which can improve their future performance. The authors propose a model which includes sustainable practices i.e., green, agile, resilient, flexible delivery of medicines. This proposal model is value-added with a weak and strong sustainable practices identification technique. This research deals with an application of a fuzzy-based Incentre of Centroid technique on proposed sustainability and is an assessment model for identifying the ill and strong chief indices, so that pharmaceutical companies can improve performance. An empirical research case of a pharmaceutical firm is presented to exhibit the real-life application of the research work.

Request Access

You do not own this content. Please login to recommend this title to your institution's librarian or purchase it from the IGI Global bookstore.